Comparing Metronidazole Topical vs Mirvaso
| Metronidazole topical | Mirvaso (brimonidine) |
|
|---|
| Metronidazole topical | Mirvaso (brimonidine) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Rosacea, Perioral Dermatitis, Bacterial Vaginosis, Balanoposthitis. Metronidazole topical may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Rosacea. Mirvaso may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||
| More about Metronidazole topical | More about Mirvaso (brimonidine) | ||||||||
| Ratings & Reviews | |||||||||
|
Metronidazole topical has an average rating of 6.7 out of 10 from a total of 346 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 23% reported a negative effect. |
Mirvaso has an average rating of 3.2 out of 10 from a total of 178 ratings on Drugs.com. 20% of reviewers reported a positive effect, while 74% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Metronidazole topical side effects |
View all Mirvaso side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Metronidazole topical prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| MetroCream, MetroGel, MetroGel-Vaginal, MetroLotion, Noritate, Nuvessa, Rosaclear, Rosadan, Vandazole View more |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
N/A |
N/A |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 8 drugs are known to interact with Metronidazole topical:
|
A total of 369 drugs are known to interact with Mirvaso:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
| First Approval Date | |||||||||
|
November 22, 1988 |
August 23, 2013 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.